Associate Professor of Biomedical Engineering, Johns Hopkins School of Medicine
Dr. Kim’s research focuses on the mechanobiology of human diseases and the development of human tissue/organ-on-a-chip platform technologies for disease modeling and drug screening. His current research at Hopkins includes heart-on-a-chip technologies, microfabricated platforms for drug-induced cardiotoxicity screening, and human stem cell-based cardiac disease modeling. Kim is also a founder of NanoSurface Biomedical (now Curi Bio), which is focused on integrating human-induced pluripotent stem cell (iPSC)-derived cells, tissue-specific biosystems, and AI-enabled data analytics to accelerate the discovery of new therapeutics. Recently, Kim and his team sent an engineered heart tissue platform to the International Space Station (ISS) National Laboratory.